KLISIC, A. et al. Serum galectin-3 and fibroblast growth factor-23 levels in relation with type 2 diabetes and cardiovascular risk : Galectin-3 and FGF-23 in relation to diabetes and CV risk. Journal of Medical Biochemistry, v. 44, n. 1, p. 85–92, 3 Oct.2024.